Bringing together new and emerging CTNs

As part of the 2021 ACTA ASM, we held a Q & A and networking session for new and emerging Clinical Trial Networks (CTNs). The session was chaired by ACTA Board Director, Prof Chris Reid and the panellists included ACTA Chair, Prof Steve Webb, Prof Michael Berk from Mental Health Australia General CTN (MAGNET), Prof Marion Eckert from the Australasian Nursing and Midwifery Clinical Trials Network (ANMCTN), Dr Phyllis Lau from the Primary Health Care Network, and A/Prof Leila Cuttle from the Australian & New Zealand Burn Association (ANZBA).

During the session, Prof Webb spoke about how the Australian and New Zealand Intensive Care Society (ANZICS) was formed. Panellists then shared about their CTN establishment journey and how ACTA resources, and the opportunity to talk to other successful networks had helped. Some themes covered in this session were governance, funding and peer review of grant applications.

This session was well attended and was enjoyed by all. Thank you to those who attended.

Some of our session participants